Posted by Michael Wonder on 12 Aug 2019
Cystic fibrosis drugs rejected for use by NHS in Scotland
12 August 2019 - Two "life-changing" cystic fibrosis drugs have been rejected for routine use by the NHS in Scotland.
The Scottish Medicines Consortium said there were uncertainties about the long-term health benefits of Orkambi and Symkevi in relation to their costs.
Manufacturer Vertex and the Scottish government are now working "as a matter of urgency" to find a way to allow broad access for eligible patients.
